丽珠医药(01513.HK)9月26日耗资499.79万元回购13.08万股A股

Core Viewpoint - Lijun Pharmaceutical (01513.HK) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Summary by Category Company Actions - The company plans to repurchase 130,800 A-shares at a total cost of RMB 4.9979 million [1] - The buyback price per share ranges from RMB 37.99 to RMB 38.46 [1] Financial Implications - The total expenditure for the buyback represents a strategic investment in the company's own shares, potentially enhancing shareholder value [1]